This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Shandong University. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Xinyi Jiang: Innovator in Nanotechnology
Introduction
Xinyi Jiang is a prominent inventor based in Jinan, China. She has made significant contributions to the field of nanotechnology, particularly in the development of innovative drug delivery systems. Her work focuses on enhancing the therapeutic index of cancer treatments through advanced nanoconjugate designs.
Latest Patents
Xinyi Jiang holds a patent for a PEGylated ICD inducer-IDO inhibitor nanoconjugate, along with its preparation method and applications. This innovative nanoconjugate is designed to self-assemble in an aqueous medium, which reduces non-specific accumulation in MPS-related organs. It also improves passive targeting capabilities to solid tumors through the enhanced permeability and retention effect. The structural formula of the nanoconjugate includes a weight-average molecular weight ranging from 1000 to 5000, where R can be H.
Career Highlights
Xinyi Jiang is affiliated with Shandong University, where she conducts her research and development activities. Her work has garnered attention for its potential to revolutionize cancer treatment methodologies. With a focus on practical applications, she aims to bridge the gap between laboratory research and clinical use.
Collaborations
Xinyi collaborates with notable colleagues, including Wei Du and Chen Chen, who contribute to her research initiatives. Their combined expertise enhances the scope and impact of their projects.
Conclusion
Xinyi Jiang is a trailblazer in the field of nanotechnology, with her innovative approaches to drug delivery systems showing great promise for future cancer therapies. Her contributions are paving the way for advancements in medical treatments and improving patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
